Search PDMR transactions

Notifier
Name
Bent Frandsen
Reason for notification
Closely associated
No
Person discharging managerial responsibilities
Bent Frandsen
Position
Chief Executive Officer (CEO)/Managing Directory
Initial notification
Yes
Amendment
No
Details of amendment
Details of the Issuer/emission allowance market participant/auction platform/auctioneer/auction monitor
Name
Expres2ion Biotech Holding AB
LEI of Issuer
549300FJK50P1ORYJC45
Details of transaction
Type of financial instrument Financial instrument ISIN code Nature of transaction Linked to a share option programme Volume Unit Price per unit Currency code Transaction date Place of the transaction
Warrant ExpreS2ion Biotech Holding AB TO4 SE0014958328 Acquisition 6,791 Quantity 6.10594021 SEK 25/02/2021 NASDAQ STOCKHOLM AB
Warrant ExpreS2ion Biotech Holding AB TO5 SE0014958336 Disposal 891 Quantity 5.96554321 SEK 26/02/2021 NASDAQ STOCKHOLM AB
Warrant ExpreS2ion Biotech Holding AB TO5 SE0014958336 Acquisition 1,907 Quantity 5.91022549 SEK 26/02/2021 NASDAQ STOCKHOLM AB
Aggregation
Financial instrument ISIN code Nature of transaction Transaction date Place of the transaction Volume Weighted average price
ExpreS2ion Biotech Holding AB TO4 SE0014958328 Acquisition 25/02/2021 NASDAQ STOCKHOLM AB 6,791 (Quantity) 6.10594021 SEK
ExpreS2ion Biotech Holding AB TO5 SE0014958336 Disposal 26/02/2021 NASDAQ STOCKHOLM AB 891 (Quantity) 5.96554321 SEK
ExpreS2ion Biotech Holding AB TO5 SE0014958336 Acquisition 26/02/2021 NASDAQ STOCKHOLM AB 1,907 (Quantity) 5.91022549 SEK
<< Back